{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:54:46Z","timestamp":1791165286580,"version":"4.1.0"},"reference-count":77,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"vor","delay-in-days":124,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.csbj.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T12:48:01Z","timestamp":1430916481000},"page":"382-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Using Stem Cells to Model Diseases of the Outer Retina"],"prefix":"10.34133","volume":"13","author":[{"given":"Camille","family":"Yvon","sequence":"first","affiliation":[{"name":"The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor M.","family":"Ramsden","sequence":"additional","affiliation":[{"name":"The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK"},{"name":"NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, EC1V 2PD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Lane","sequence":"additional","affiliation":[{"name":"The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Powner","sequence":"additional","affiliation":[{"name":"The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndon","family":"da Cruz","sequence":"additional","affiliation":[{"name":"The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK"},{"name":"NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, EC1V 2PD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Coffey","sequence":"additional","affiliation":[{"name":"The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK"},{"name":"Center for Stem Cell Biology and Engineering, NRI, UC, Santa Barbara, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda-Jayne F.","family":"Carr","sequence":"additional","affiliation":[{"name":"The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004015"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra062326"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00021.2004"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.092270"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000357363","article-title":"Neural retinal regeneration with pluripotent stem cells","volume":"53","author":"Ramsden C.M.","year":"2014","unstructured":"Ramsden C.M., Powner M.B., Carr A.J., Smart M.J., da Cruz L. et al: Neural retinal regeneration with pluripotent stem cells. Dev Ophthalmol 2014; 53: 97.","journal-title":"Dev Ophthalmol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2013.03.006"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.674"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0905245106"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/clo.2004.6.217"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/clo.2006.8.189"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2008.09.007"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.05.009"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2009.07.002"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1073\/pnas.0500010102","article-title":"Generation of Rx+\/Pax6+ neural retinal precursors from embryonic stem cells","volume":"102","author":"Ikeda H.","year":"2005","unstructured":"Ikeda H., Osakada F., Watanabe K., Mizuseki K., Haraguchi T. et al: Generation of Rx+\/Pax6+ neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci U S A 2005; 102: 11331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.5966\/sctm.2014-0094","article-title":"Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells","volume":"3","author":"Lane A.","year":"2014","unstructured":"Lane A., Philip L.R., Ruban L., Fynes K., Smart M. et al: Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells. Stem Cells Transl Med 2014; 3: 1295.","journal-title":"Stem Cells Transl Med"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.024"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.11.019"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002085"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09871"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11629"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.07.001"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1383"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2008.07.016"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1167\/iovs.13-11943","article-title":"Functional analysis of serially expanded human iPS cell-derived RPE cultures","volume":"54","author":"Singh R.","year":"2013","unstructured":"Singh R., Phillips M.J., Kuai D., Meyer J., Martin J.M. et al: Functional analysis of serially expanded human iPS cell-derived RPE cultures. Invest Ophthalmol Vis Sci 2013; 54: 6767.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.12.005"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tice.2013.07.003","article-title":"Investigation of telomere length dynamics in induced pluripotent stem cells using quantitative fluorescence in situ hybridization","volume":"45","author":"Terai M.","year":"2013","unstructured":"Terai M., Izumiyama-Shimomura N., Aida J., Ishikawa N., Kuroiwa M. et al: Investigation of telomere length dynamics in induced pluripotent stem cells using quantitative fluorescence in situ hybridization. Tissue Cell 2013; 45: 407.","journal-title":"Tissue Cell"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008152"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep08344"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2009.04.035","article-title":"Generation of retinal cells from mouse and human induced pluripotent stem cells","volume":"458","author":"Hirami Y.","year":"2009","unstructured":"Hirami Y., Osakada F., Takahashi K., Okita K., Yamanaka S. et al: Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009; 458: 126.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1167\/iovs.11-9313","article-title":"Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses","volume":"53","author":"Phillips M.J.","year":"2012","unstructured":"Phillips M.J., Wallace K.A., Dickerson S.J., Miller M.J., Verhoeven A.D. et al: Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci 2012; 53: 2007.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5047"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22814"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi345"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1285"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq341"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.149"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.11.006"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910012107"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2014.104"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000072042","article-title":"Retinitis pigmentosa: genes, proteins and prospects","volume":"37","author":"Hims M.M.","year":"2003","unstructured":"Hims M.M., Diager S.P. and Inglehearn C.F.: Retinitis pigmentosa: genes, proteins and prospects. Dev Ophthalmol 2003; 37: 109.","journal-title":"Dev Ophthalmol"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/hmg\/11.10.1219","article-title":"Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns","volume":"11","author":"Rivolta C.","year":"2002","unstructured":"Rivolta C., Sharon D., DeAngelis M.M. and Dryja T.P.: Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet 2002; 11: 1219.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_43_2","first-page":"127","article-title":"Advances in gene therapy technologies to treat retinitis pigmentosa","volume":"8","author":"Petrs-Silva H.","year":"2014","unstructured":"Petrs-Silva H. and Linden R.: Advances in gene therapy technologies to treat retinitis pigmentosa. Clin Ophthalmol 2014; 8: 127.","journal-title":"Clin Ophthalmol"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017084"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-6606-7-45","article-title":"The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa","volume":"7","author":"Yoshida T.","year":"2014","unstructured":"Yoshida T., Ozawa Y., Suzuki K., Yuki K., Ohyama M. et al: The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa. Mol Brain 2014; 7: 45.","journal-title":"Mol Brain"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"E569","DOI":"10.1073\/pnas.1108918108","article-title":"Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa","volume":"108","author":"Tucker B.A.","year":"2011","unstructured":"Tucker B.A., Scheetz T.E., Mullins R.F., DeLuca A.P., Hoffmann J.M. et al: Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci U S A 2011; 108: E569.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1167\/iovs.11-8527","article-title":"Autosomal recessive retinitis pigmentosa caused by mutations in the MAK gene","volume":"52","author":"Stone E.M.","year":"2011","unstructured":"Stone E.M., Luo X., Heon E., Lam B.L., Weleber R.G. et al: Autosomal recessive retinitis pigmentosa caused by mutations in the MAK gene. Invest Ophthalmol Vis Sci 2011; 52: 9665.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/hmg\/ddu509","article-title":"Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells","volume":"24","author":"Schwarz N.","year":"2015","unstructured":"Schwarz N., Carr A.J., Lane A., Moeller F., Chen L.L. et al: Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet 2015 Feb 15; 24: 972.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.100"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat N.","year":"2012","unstructured":"Nayerossadat N., Maedeh T. and Ali P.A.: Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 2012; 1: 27.","journal-title":"Adv Biomed Res"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1089\/scd.2011.0599","article-title":"A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells","volume":"21","author":"Zahabi A.","year":"2012","unstructured":"Zahabi A., Shahbazi E., Ahmadieh H., Hassani S.N., Totonchi M. et al: A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev 2012; 21: 2262.","journal-title":"Stem Cells Dev"},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"e00824","DOI":"10.7554\/eLife.00824","article-title":"Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa","volume":"2","author":"Tucker B.A.","year":"2013","unstructured":"Tucker B.A., Mullins R.F., Streb L.M., Anfinson K., Eyestone M.E. et al: Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. Elife 2013; 2: e00824.","journal-title":"Elife"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802315"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2014.39"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2008.05.003"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21337"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1083\/jcb.201006105","article-title":"CEP290 tethers flagellar transition zone microtubules to the membrane and regulates flagellar protein content","volume":"190","author":"Craige B.","year":"2010","unstructured":"Craige B., Tsao C.C., Diener D.R., Hou Y., Lechtreck K.F. et al: CEP290 tethers flagellar transition zone microtubules to the membrane and regulates flagellar protein content. J Cell Biol 2010; 190: 927.","journal-title":"J Cell Biol"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69448"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0704140104"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2008.07.004"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2009.04.008"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0501-92"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802268"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0807027105"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2008.107"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5years after vector administration","volume":"18","author":"Simonelli F.","year":"2010","unstructured":"Simonelli F., Maguire A.M., Testa F., Pierce E.A., Mingozzi F. et al: Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5years after vector administration. Mol Ther 2010; 18: 643.","journal-title":"Mol Ther"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-61779-370-7_8","article-title":"Adeno-associated virus mediated gene therapy for retinal degenerative diseases","volume":"807","author":"Stieger K.","year":"2011","unstructured":"Stieger K., Cronin T., Bennett J. and Rolling F.: Adeno-associated virus mediated gene therapy for retinal degenerative diseases. Methods Mol Biol 2011; 807: 179.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1089\/cell.2012.0076"},{"key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/08830738040190010703","article-title":"Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect","volume":"19","author":"de los Reyes E.","year":"2004","unstructured":"de los Reyes E., Dyken P.R., Phillips P., Brodsky M., Bates S. et al: Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. J Child Neurol 2004; 19: 42.","journal-title":"J Child Neurol"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile Batten disease mice","volume":"230","author":"Seehafer S.S.","year":"2010","unstructured":"Seehafer S.S., Ramirez-Montealegre D., Wong A.M.S., Chan C.-H., Castaneda J. et al: Immunosuppression alters disease severity in juvenile Batten disease mice. J Neuroimmunol 2010; 230: 169.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/hmg\/ddt596","article-title":"Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway","volume":"23","author":"Lojewski X.","year":"2014","unstructured":"Lojewski X., Staropoli J.F., Biswas-Legrand S., Simas A.M., Haliw L. et al: Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet 2014; 23: 2005.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_72_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-4547(19990815)57:4<551::AID-JNR15>3.0.CO;2-R","article-title":"A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease)","volume":"57","author":"Katz M.L.","year":"1999","unstructured":"Katz M.L., Shibuya H., Liu P.-C., Kaur S., Gao C.-L. et al: A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease). J Neurosci Res 1999; 57: 551.","journal-title":"J Neurosci Res"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/915"},{"key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archophthalmol.2011.363","article-title":"Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with Best vitelliform macular dystrophy","volume":"130","author":"Kay C.N.","year":"2012","unstructured":"Kay C.N., Abramoff M.D., Mullins R.F., Kinnick T.R., Lee K. et al: Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with Best vitelliform macular dystrophy. Arch Ophthalmol 2012; 130: 357.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_1_75_2","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1167\/iovs.06-0868","article-title":"Differential macular and peripheral expression of bestrophin in human eyes and its implication for Best disease","volume":"48","author":"Mullins R.F.","year":"2007","unstructured":"Mullins R.F., Kuehn M.H., Faidley E.A., Syed N.A. and Stone E.M.: Differential macular and peripheral expression of bestrophin in human eyes and its implication for Best disease. Invest Ophthalmol Vis Sci 2007; 48: 3372.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_1_76_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/hmg\/dds469","article-title":"iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration","volume":"22","author":"Singh R.","year":"2013","unstructured":"Singh R., Shen W., Kuai D., Martin J.M., Guo X. et al: iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 2013; 22: 593.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu053"},{"key":"e_1_3_1_78_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fnagi.2014.00191","article-title":"The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress","volume":"6","author":"Chang Y.C.","year":"2014","unstructured":"Chang Y.C., Chang W.C., Hung K.H., Yang D.M., Cheng Y.H. et al: The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress. Front Aging Neurosci 2014; 6: 191.","journal-title":"Front Aging Neurosci"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037015000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037015000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2015.05.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:52:59Z","timestamp":1778014379000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2015.05.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":77,"alternative-id":["10.1016\/j.csbj.2015.05.001"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2015.05.001","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Stem Cells to Model Diseases of the Outer Retina","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}